Bose S - Search Results

1

Overexpression of beta1-chain-containing laminins in capillary basement membranes of human breast cancer and its metastases.

Fujita M, Khazenzon NM, Bose S, Sekiguchi K, Sasaki T, Carter WG, Ljubimov AV, Black KL, Ljubimova JY. Fujita M, et al. Among authors: bose s. Breast Cancer Res. 2005;7(4):R411-21. doi: 10.1186/bcr1011. Epub 2005 Apr 6. Breast Cancer Res. 2005. PMID: 15987446 Free PMC article.

2

BRCA-mutated Invasive Breast Carcinomas: Immunohistochemical Analysis of Insulin-like Growth Factor II mRNA-binding Protein (IMP3), Cytokeratin 8/18, and Cytokeratin 14.

Mohanty SK, Lai JP, Gordon OK, Pradhan D, Bose S, Dadmanesh F. Mohanty SK, et al. Among authors: bose s. Breast J. 2015 Nov-Dec;21(6):596-603. doi: 10.1111/tbj.12494. Epub 2015 Sep 22. Breast J. 2015. PMID: 26390986

3

The Akt pathway in human breast cancer: a tissue-array-based analysis.

Bose S, Chandran S, Mirocha JM, Bose N. Bose S, et al. Among authors: bose n. Mod Pathol. 2006 Feb;19(2):238-45. doi: 10.1038/modpathol.3800525. Mod Pathol. 2006. PMID: 16341149 Free article.

4

Unmasking of epigenetically silenced genes reveals DNA promoter methylation and reduced expression of PTCH in breast cancer.

Wolf I, Bose S, Desmond JC, Lin BT, Williamson EA, Karlan BY, Koeffler HP. Wolf I, et al. Among authors: bose s. Breast Cancer Res Treat. 2007 Oct;105(2):139-55. doi: 10.1007/s10549-006-9440-4. Epub 2007 Feb 13. Breast Cancer Res Treat. 2007. PMID: 17295047

5

Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery.

Changsri C, Prakash S, Sandweiss L, Bose S. Changsri C, et al. Among authors: bose s. Breast J. 2004 Sep-Oct;10(5):392-7. doi: 10.1111/j.1075-122X.2004.21446.x. Breast J. 2004. PMID: 15327491

6

Securin is overexpressed in breast cancer.

Ogbagabriel S, Fernando M, Waldman FM, Bose S, Heaney AP. Ogbagabriel S, et al. Among authors: bose s. Mod Pathol. 2005 Jul;18(7):985-90. doi: 10.1038/modpathol.3800382. Mod Pathol. 2005. PMID: 15846392 Free article.

7

Reduced expression of PTEN correlates with breast cancer progression.

Bose S, Crane A, Hibshoosh H, Mansukhani M, Sandweis L, Parsons R. Bose S, et al. Hum Pathol. 2002 Apr;33(4):405-9. doi: 10.1053/hupa.2002.124721. Hum Pathol. 2002. PMID: 12055674

8

FOXA1: Growth inhibitor and a favorable prognostic factor in human breast cancer.

Wolf I, Bose S, Williamson EA, Miller CW, Karlan BY, Koeffler HP. Wolf I, et al. Among authors: bose s. Int J Cancer. 2007 Mar 1;120(5):1013-22. doi: 10.1002/ijc.22389. Int J Cancer. 2007. PMID: 17163418

9

PTEN promoter is methylated in a proportion of invasive breast cancers.

Khan S, Kumagai T, Vora J, Bose N, Sehgal I, Koeffler PH, Bose S. Khan S, et al. Among authors: bose n, bose s. Int J Cancer. 2004 Nov 10;112(3):407-10. doi: 10.1002/ijc.20447. Int J Cancer. 2004. PMID: 15382065

10

Basal Protein Expression Is Associated With Worse Outcome and Trastuzamab Resistance in HER2+ Invasive Breast Cancer.

Chung A, Choi M, Han BC, Bose S, Zhang X, Medina-Kauwe L, Sims J, Murali R, Taguiam M, Varda M, Schiff R, Giuliano A, Cui X. Chung A, et al. Among authors: bose s. Clin Breast Cancer. 2015 Dec;15(6):448-457.e2. doi: 10.1016/j.clbc.2015.06.001. Epub 2015 Jun 19. Clin Breast Cancer. 2015. PMID: 26248960 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,510 results

Search Page

Filters